Defining the Value of Interventional Radiology to Healthcare Stakeholders: Proceedings from a Society of Interventional Radiology Research Consensus Panel.

C Matthew Hawkins¹, Richard Duszak², Danny R Hughes³, Ray Liu⁴, Andrew S Resnick⁵, David A Kooby⁶, Jeremy C Durack⁷, John A Kaufman⁸, Frank Dubeck⁹, Mark B Canada¹⁰, Katharine L Krol¹¹, Sarah B White¹²

¹Department of Radiology and Imaging Sciences, Emory University School of Medicine Atlanta, Georgia; Division of Pediatric Radiology, Children's Pediatric Institute; Children's Healthcare of Atlanta, Atlanta, Georgia. Electronic address: Matt.hawkins@emory.edu.

²Department of Radiology and Imaging Sciences, Emory University School of Medicine Atlanta, Georgia.

³School of Economics, Health Economics and Analytics Lab, Georgia Institute of Technology, Atlanta, Georgia.

⁴Department of Radiology, Massachusetts General, Boston, Massachusetts.

⁵Department of Quality and Safety, Brigham and Women's Hospital, Boston, Massachusetts.

⁶Department of Surgery, Winship Cancer Institute, Emory University School of Medicine Atlanta, Georgia.

⁷Division of Interventional Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.

⁸Dotter Department of Interventional Radiology, Oregon Health and Science University, Portland, Oregon.

⁹Change Healthcare, Inc., Nashville, Tennessee.

¹⁰Radiology Associates of Richmond, Inc., Richmond, Virginia.

¹¹SIR Foundation, Fairfax, Virginia.

¹²Division of Vascular and Interventional Radiology, Department of Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin.

PubMed DOI

Abstract

Interventional radiology (IR) has collectively struggled to articulate and prove its value to several external stakeholders. The goal of this research consensus panel was to provide a summary of the existing knowledge, identify current gaps in knowledge, identify the strengths and weaknesses in existing data, and prioritize research needs related to the value of IR. Panelists were asked to identif…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.